Kahira Pharmaceuticals
Last Updated:
- 36.56 EGP
- 1.26
- 3.57%
القاهرة للادوية والصناعات الكيماوية
القاهرة للادوية
Symbol :
CPCI
ISIN :
EGS38391C016
52-Week Range :
25.60
-
39.79
Turnover Ratio :
0.12
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Kahira Pharmaceuticals Announcements
Top News
- A 14-February Kahira Pharmaceuticals' net profits up 22.5% in H1-21/22
- B 26-January Kahira Pharmaceuticals sees EGP 9m block trading deal
- C 06-June Adel Taha Abdel Wahab named Chairman of Kahira Pharmaceuticals
- D 05-May Kahira Pharmaceuticals posts 12% higher profit in nine months
- E 16-February Kahira Pharmaceuticals targets EGP 145m profit in FY21/22
- F 20-October Pharma stocks lead EGX ahead of potential acquisitions
- G 30-August Kahira Pharmaceuticals sees 28% profit rise in FY19/20
- H 10-August Kahira Pharmaceuticals posts 34% profit growth in FY19/20 initial results
- I 13-May Kahira Pharmaceuticals reports 28% profit rise in 9M
- J 10-February Kahira Pharmaceuticals posts 29% profit hike in H1-19/20 unaudited financials
- K 13-November Kahira Pharmaceuticals’ profit down 18% in Q1-19/20 unaudited financials
- L 29-September Kahira Pharmaceuticals approves dividends, bonus shares for FY18/19
